Have a symptom?
See what questions
a doctor would ask.
Diseases » Uveitis » Prevalence

Prevalence and Incidence of Uveitis

Prevalance of Uveitis:

2,300,000 people suffer uveitis in the US (Research to Prevent Blindness, NISE, NSF) ... see also overview of Uveitis.

Prevalance Rate:

approx 1 in 118 or 0.85% or 2.3 million people in USA [Source statistic for calcuation: "2,300,000 people suffer uveitis in the US (Research to Prevent Blindness, NISE, NSF)" -- see also general information about data sources]

Prevalance of types of Uveitis:

For details see prevalence of types of Uveitis analysis; summary of available prevalence data:

Uveitis: Rare Disease

Uveitis is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Uveitis, or a subtype of Uveitis, affects less than 200,000 people in the US population.

About prevalence and incidence statistics:

The term 'prevalence' of Uveitis usually refers to the estimated population of people who are managing Uveitis at any given time. The term 'incidence' of Uveitis refers to the annual diagnosis rate, or the number of new cases of Uveitis diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

1. Rose and Mackay, 1998, The Autoimmune Diseases, Third Edition


By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise